Construction of the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology
Thanks to a donation totaling JPY 5.5 billion (or approximately USD 53 million) from Bristol Myers Squibb K.K., as well as subsidies from the Japanese government, the Center for Cancer Immunotherapy and Immunobiology has elected to construct its main building at the Kyoto University Faculty of Medicine Campus. The Building will be named the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology.
The appearance of the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology was drawn by Mr. Tadao Ando, who is an internationally renowned Japanese architect. His layout for the Building is comprised of two central design themes—"circular design”, represented by an image of immune cells, and color which represents a gentle cell membrane. The symbolic appearance of the Building is considered appropriate for the first-ever Japanese comprehensive research institute dedicated to cancer immunotherapy research.
Construction of the Building is scheduled to be completed in 2023.
Outline of the Bristol Myers Squibb Building at the Center for Cancer Immunotherapy and Immunobiology
Building Area: Approximately 1,700㎡
Total Floor Area: Approximately 9,500㎡
Structure: Reinforced concrete construction of five stories above the ground and one basement floor.
Basic Design: Tadao Ando Architect & Associates / Kyoto University Facilities Department
(Construction) Educational Facilities Institute Co., Ltd.
(Equipment) SOGO CONSULTANTS
Appearance of the Bristol Myers Squibb Buidling at the Center for Cancer Immunotherapy and Immunobiology (Drawn by Mr. Tadao Ando)
Press Releases/Press Reports
- Press Release by Kyoto University (in Japanese)
- Press Release by Bristol-Myers Squibb K.K.
- PHARMA JAPAN